Levamisole treatment of acute viral hepatitis and HBs Ag-positive chronic active hepatitis

A. Pár, K. Barna, G. Bajtai, I. Hollós, M. Ambrus, M. Kovács, T. Jávor

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A fundamental role is attributed to the pathological immune response in the development of chronic hepatitis B. By virtue of its non-specific immune modulatory effect, levamisole is capable of improving impaired T-cell function. Hence, studies with treated and control groups were performed to determine the effect of levamisole in acute viral hepatitis and chronic active hepatitis B. In acute hepatitis B, levamisole promoted the normalization of GPT, the elimination of HBsAg; this improvement was preceded by higher GPT values and increased titres of IgG, IgA, and of anti-HB (core). In chronic active hepatitis in the first few months of treatment a moderate increase of the GPT and HBsAg levels occurred, followed later by a decrease of these values. At the same time the phytohaemagglutinin reactivity of lymphocytes increased, and so did the ratio of circulating active T-cells.

Original languageEnglish
Pages (from-to)269-281
Number of pages13
JournalActa Medica Academiae Scientiarum Hungaricae
Volume37
Issue number3
Publication statusPublished - 1980

Fingerprint

Levamisole
Chronic Hepatitis
Hepatitis
Chronic Hepatitis B
Hepatitis B Surface Antigens
T-Lymphocytes
Phytohemagglutinins
Hepatitis B
Lymphocytes
Control Groups

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pár, A., Barna, K., Bajtai, G., Hollós, I., Ambrus, M., Kovács, M., & Jávor, T. (1980). Levamisole treatment of acute viral hepatitis and HBs Ag-positive chronic active hepatitis. Acta Medica Academiae Scientiarum Hungaricae, 37(3), 269-281.

Levamisole treatment of acute viral hepatitis and HBs Ag-positive chronic active hepatitis. / Pár, A.; Barna, K.; Bajtai, G.; Hollós, I.; Ambrus, M.; Kovács, M.; Jávor, T.

In: Acta Medica Academiae Scientiarum Hungaricae, Vol. 37, No. 3, 1980, p. 269-281.

Research output: Contribution to journalArticle

Pár, A, Barna, K, Bajtai, G, Hollós, I, Ambrus, M, Kovács, M & Jávor, T 1980, 'Levamisole treatment of acute viral hepatitis and HBs Ag-positive chronic active hepatitis', Acta Medica Academiae Scientiarum Hungaricae, vol. 37, no. 3, pp. 269-281.
Pár, A. ; Barna, K. ; Bajtai, G. ; Hollós, I. ; Ambrus, M. ; Kovács, M. ; Jávor, T. / Levamisole treatment of acute viral hepatitis and HBs Ag-positive chronic active hepatitis. In: Acta Medica Academiae Scientiarum Hungaricae. 1980 ; Vol. 37, No. 3. pp. 269-281.
@article{abdf2b6bff0d49aa95233d3d7ad4ce0e,
title = "Levamisole treatment of acute viral hepatitis and HBs Ag-positive chronic active hepatitis",
abstract = "A fundamental role is attributed to the pathological immune response in the development of chronic hepatitis B. By virtue of its non-specific immune modulatory effect, levamisole is capable of improving impaired T-cell function. Hence, studies with treated and control groups were performed to determine the effect of levamisole in acute viral hepatitis and chronic active hepatitis B. In acute hepatitis B, levamisole promoted the normalization of GPT, the elimination of HBsAg; this improvement was preceded by higher GPT values and increased titres of IgG, IgA, and of anti-HB (core). In chronic active hepatitis in the first few months of treatment a moderate increase of the GPT and HBsAg levels occurred, followed later by a decrease of these values. At the same time the phytohaemagglutinin reactivity of lymphocytes increased, and so did the ratio of circulating active T-cells.",
author = "A. P{\'a}r and K. Barna and G. Bajtai and I. Holl{\'o}s and M. Ambrus and M. Kov{\'a}cs and T. J{\'a}vor",
year = "1980",
language = "English",
volume = "37",
pages = "269--281",
journal = "Acta Medica Academiae Scientiarum Hungaricae",
issn = "0001-5989",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Levamisole treatment of acute viral hepatitis and HBs Ag-positive chronic active hepatitis

AU - Pár, A.

AU - Barna, K.

AU - Bajtai, G.

AU - Hollós, I.

AU - Ambrus, M.

AU - Kovács, M.

AU - Jávor, T.

PY - 1980

Y1 - 1980

N2 - A fundamental role is attributed to the pathological immune response in the development of chronic hepatitis B. By virtue of its non-specific immune modulatory effect, levamisole is capable of improving impaired T-cell function. Hence, studies with treated and control groups were performed to determine the effect of levamisole in acute viral hepatitis and chronic active hepatitis B. In acute hepatitis B, levamisole promoted the normalization of GPT, the elimination of HBsAg; this improvement was preceded by higher GPT values and increased titres of IgG, IgA, and of anti-HB (core). In chronic active hepatitis in the first few months of treatment a moderate increase of the GPT and HBsAg levels occurred, followed later by a decrease of these values. At the same time the phytohaemagglutinin reactivity of lymphocytes increased, and so did the ratio of circulating active T-cells.

AB - A fundamental role is attributed to the pathological immune response in the development of chronic hepatitis B. By virtue of its non-specific immune modulatory effect, levamisole is capable of improving impaired T-cell function. Hence, studies with treated and control groups were performed to determine the effect of levamisole in acute viral hepatitis and chronic active hepatitis B. In acute hepatitis B, levamisole promoted the normalization of GPT, the elimination of HBsAg; this improvement was preceded by higher GPT values and increased titres of IgG, IgA, and of anti-HB (core). In chronic active hepatitis in the first few months of treatment a moderate increase of the GPT and HBsAg levels occurred, followed later by a decrease of these values. At the same time the phytohaemagglutinin reactivity of lymphocytes increased, and so did the ratio of circulating active T-cells.

UR - http://www.scopus.com/inward/record.url?scp=0019258647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019258647&partnerID=8YFLogxK

M3 - Article

C2 - 7457030

AN - SCOPUS:0019258647

VL - 37

SP - 269

EP - 281

JO - Acta Medica Academiae Scientiarum Hungaricae

JF - Acta Medica Academiae Scientiarum Hungaricae

SN - 0001-5989

IS - 3

ER -